Skip to main content

Table 2 Differential expression of circulating HCMV-encoded miRNAs under various disease conditions

From: Altered human cytomegalovirus-encoded miRNAs in host circulation: novel disease biomarkers and potential aetiological agents

HCMV-encoded miRNA Sample type Diseases Alteration References
hcmv-miR-UL112 Plasma Essential hypertension Upregulation [32]
Plasma Type 2 diabetes Upregulation [81]
Plasma Glioblastoma Upregulation [81]
hcmv-miR-US5-1, hcmv-miR-US-5-2-3p, hcmv-miR-UL-22a-5p, hcmv-miR-US25-1-5p, hcmv-miR-US-25-2-3p, hcmv-miR-US-25-2-5p, hcmv-miR-US-33-3p, hcmv-miR-UL36-5p, hcmv-miR-UL112-3p Blood Solid organ transplantation Upregulation [83]
hcmv-miR-US25-1-5p, hcmv-miR-US25-2-5p Plasma Congenital CMV infection Upregulation [84]
hcmv-miR-US33-5p Plasma Acute aortic dissection Upregulation [86]
hcmv-miR-US4-1, hcmv-miR-UL-148D Serum IFNα treatment non-responsive chronic hepatitis B Upregulation [87]
hcmv-miR-UL112-3p, hcmv-miR-UL22a-5p, hcmv-miR-UL148d, hcmv-miR-UL36-5p, hcmv-miR-UL59 Serum Oral lichen planus Upregulation [35]